Stockscreener 앱 받기
115.48
0.82%
0.94
시간 외 거래:
115.48
전일 마감가:
$114.54
열려 있는:
$113.91
하루 거래량:
1.11M
Relative Volume:
0.51
시가총액:
$32.63B
수익:
$7.07B
순이익/손실:
$1.29B
주가수익비율:
25.46
EPS:
4.5355
순현금흐름:
$993.00M
1주 성능:
+1.76%
1개월 성능:
-2.28%
6개월 성능:
-16.74%
1년 성능:
-0.44%
1일 변동 폭
$112.99
$117.32
1주일 범위
$109.90
$117.32
52주 변동 폭
$96.43
$160.27
애질런트 테크놀로지스 Stock (A) Company Profile
명칭
Agilent Technologies Inc
전화
(408) 345-8886
주소
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
115.48 | 32.37B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 183.71B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.02B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 44.85B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
304.24 | 29.42B | 3.17B | 642.63M | 516.49M | 10.77 |
애질런트 테크놀로지스 Stock (A) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 개시 | HSBC Securities | Buy |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-08 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-24 | 재확인 | BofA Securities | Buy |
| 2023-05-24 | 재확인 | Citigroup | Neutral |
| 2023-05-24 | 재확인 | Credit Suisse | Outperform |
| 2023-05-24 | 재확인 | Evercore ISI | Outperform |
| 2023-05-24 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 재확인 | Robert W. Baird | Outperform |
| 2023-05-24 | 재확인 | SVB Securities | Outperform |
| 2023-05-24 | 재확인 | Stifel | Hold |
| 2023-05-24 | 재확인 | TD Cowen | Outperform |
| 2023-05-24 | 재확인 | Wells Fargo | Overweight |
| 2023-05-11 | 개시 | Barclays | Equal Weight |
| 2023-01-10 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-07-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 재확인 | BofA Securities | Buy |
| 2022-02-23 | 재확인 | Citigroup | Buy |
| 2022-02-23 | 재확인 | Cowen | Outperform |
| 2022-02-23 | 재확인 | Evercore ISI | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-23 | 재확인 | Wells Fargo | Overweight |
| 2021-11-23 | 재확인 | BofA Securities | Buy |
| 2021-11-23 | 재확인 | Cowen | Outperform |
| 2021-11-23 | 재확인 | Stifel | Hold |
| 2021-03-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 업그레이드 | UBS | Neutral → Buy |
| 2020-11-17 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 개시 | Atlantic Equities | Neutral |
| 2020-08-19 | 재확인 | BofA Securities | Neutral |
| 2020-08-19 | 재확인 | Citigroup | Neutral |
| 2020-08-19 | 재확인 | Jefferies | Buy |
| 2020-08-19 | 재확인 | Robert W. Baird | Outperform |
| 2020-08-19 | 재확인 | SVB Leerink | Outperform |
| 2020-08-19 | 재확인 | Stifel | Hold |
| 2020-08-19 | 재확인 | Wells Fargo | Overweight |
| 2020-02-24 | 다운그레이드 | Needham | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-26 | 재확인 | Needham | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | 다운그레이드 | Barclays | Overweight → Equal Weight |
모두보기
애질런트 테크놀로지스 주식(A)의 최신 뉴스
Lab chromatographs are getting smarter: what Agilent is quietly changing for US labs - AD HOC NEWS
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Henson Meghan - Moomoo
Agilent (NYSE: A) SVP surrenders shares to cover RSU tax bill - Stock Titan
Agilent Technologies Reports Fourth-Quarter 2012 Results - Yahoo
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader - biospace.com
Agilent's Local Strategy Cuts Supply Chain Risk, Drives India Growth - Whalesbook
Agilent Technologies “in country, for country” strategy helps mitigate supply disruptions - BusinessLine
Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai - BioSpectrum India
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents - PR Newswire
Agilent Technologies Announces Cash Dividend of 12 Cents per Share - Yahoo
Agilent (A) Unveils Innovative BioTek Cytation 9 Cell Imaging Re - GuruFocus
Agilent Technologies Inc Announces the Biotek Cytation 9 Cell Imaging Multimode Reader - MarketScreener
Flow Cytometry Market Is Booming So Rapidly | Agilent Technologies Inc. • Danaher • Enzo Life Sciences Inc - openPR.com
Agilent launches Cytation 9 cell imaging multimode reader - Investing.com
Agilent Technologies, Inc. $A Shares Purchased by Vaughan Nelson Investment Management L.P. - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Scharf Investments LLC - MarketBeat
Agilent Technologies Inc. stock rises Tuesday, still underperforms market - MarketWatch
Agilent Technologies (A) to acquire Biocare Medical for $950M - MSN
SNP Genotyping and Analysis Market to See Booming Growth - openPR.com
J. Safra Sarasin Holding AG Sells 39,952 Shares of Agilent Technologies, Inc. $A - MarketBeat
Dissolution Online Systems Market Is Going to Boom | Agilent Technologies • Merck KGaA • PerkinElmer - openPR.com
Forecast Cut: Whats the beta of Agilent Technologies Inc stockMarket Weekly Review & Expert Verified Movement Alerts - baoquankhu1.vn
Agilent Technologies, Inc.: - MarketScreener
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies price faces negative outlookForecast today30-03-2026 - Economies.com
Agilent Technologies Adjusts Valuation Amid Strong Institutional Support and Financial Metrics - marketsmojo.com
Agilent Technologies' Advanced Chromatography Solutions: Driving Precision Analytics in North Americ - AD HOC NEWS
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why Is Agilent (A) Down 6.2% Since Last Earnings Report? - ca.finance.yahoo.com
Is It Time To Consider Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
There's A Lot To Like About Agilent Technologies' (NYSE:A) Upcoming US$0.255 Dividend - simplywall.st
Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx - Yahoo Finance
Agilent Technologies Inc. stock: Precision instruments leader navigating life sciences and diagnosti - AD HOC NEWS
A Stock Price, Quote & Chart | AGILENT TECHNOLOGIES INC (NYSE:A) - ChartMill
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma - BioSpace
Vanguard disaggregates holdings after realignment — Agilent (NYSE: A) - Stock Titan
Agilent Technologies (A) Gains FDA Approval for Diagnostic Tool in KEYTRUDA Treatment - GuruFocus
Agilent Technologies Inc. stock climbs on launch of advanced chromatography solutions boosting life - AD HOC NEWS
Agilent Technologies Inc. stock climbs amid new chromatography solutions launch signaling life scien - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Aug Weekly: Will Agilent Technologies Inc benefit from current market trends2026 Big Picture & Momentum Based Trading Signals - baoquankhu1.vn
Pensionfund Sabic Buys New Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) latest stock news and headlines - Yahoo Finance Singapore
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting lab effic - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting life scie - AD HOC NEWS
Board Member At Agilent Technologies Buys $241K of Stock - Benzinga
Agilent Technologies (A) to Acquire Biocare Medical for $950M - Insider Monkey
Agilent Technologies Faces Mixed Technical Signals Amid Valuation Adjustments - marketsmojo.com
SG Americas Securities LLC Has $109.97 Million Position in Agilent Technologies, Inc. $A - MarketBeat
A SEC FilingsAgilent Technologies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
애질런트 테크놀로지스 (A) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
1.11%
자본화:
|
볼륨(24시간):